Advancing precision neurology

This article discusses current opportunities in precision neurology, focusing on key biomarkers that help with the differential diagnosis of neurologic conditions as well as stratification of subjects for clinical trials focusing on Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS) and related disorders.